Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
JRSM Open ; 15(6): 20542704231200394, 2024 Jun.
Article in English | MEDLINE | ID: mdl-39091433

ABSTRACT

Pulmonary sclerosing pneumocytoma (PSP) is a rare benign pulmonary tumour, most reported cases of PSP are from Eastern Asia, with a female to male ratio of 5:1, and average age at diagnosis in the 5th decade. We present the case of a 63-year-old Caucasian woman diagnosed with PSP who underwent a left lower lobe basal segmentectomy with systematic nodal dissection, performed via video assisted thoracic surgery (VATS).

2.
Histopathology ; 84(1): 18-31, 2024 Jan.
Article in English | MEDLINE | ID: mdl-37867404

ABSTRACT

Invasive mucinous adenocarcinoma (IMA) is a relatively rare subtype of lung adenocarcinoma, composed of goblet and/or columnar tumour cells containing abundant intracytoplasmic mucin vacuoles. While a majority of IMAs are driven by KRAS mutations, recent studies have identified distinct genomic alterations, such as NRG1 and ERBB2 fusions. IMAs also more frequently present as a pneumonic-like pattern with multifocal and multilobar involvement, and comparative genomic profiling predominantly shows a clonal relationship, suggesting intrapulmonary metastases rather than synchronous primary tumours. Accordingly, these unique features require different therapeutic approaches when compared to nonmucinous adenocarcinomas in general. In this article, we review recent updates on the histopathological, clinical, and molecular features of IMAs, and also highlight some unresolved issues for future studies.


Subject(s)
Adenocarcinoma of Lung , Adenocarcinoma, Mucinous , Adenocarcinoma , Lung Neoplasms , Humans , Lung Neoplasms/pathology , Adenocarcinoma, Mucinous/pathology , Adenocarcinoma/genetics , Adenocarcinoma/pathology , Mutation
SELECTION OF CITATIONS
SEARCH DETAIL